Profil
Nathan Stasko was the founder of NVN Liquidation, Inc. since 2006, serving as President, Director & Chief Scientific Officer from 2017 to 2019.
Dr. Stasko is currently the Chief Executive Officer & Director at Vast Therapeutics, Inc. since 2022.
Formerly, Dr. Stasko was a Director at KNOW Bio LLC.
Aktive Positionen von Nathan Stasko
| Unternehmen | Position | Beginn |
|---|---|---|
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Vorstandsvorsitzender | 01.03.2022 |
Ehemalige bekannte Positionen von Nathan Stasko
| Unternehmen | Position | Ende |
|---|---|---|
| NVN LIQUIDATION, INC. | Vorstandsvorsitzender | 05.06.2017 |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
NVN Liquidation, Inc.
NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Health Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Health Technology |
















